Department of Thoracic Surgery, University Hospital Basel, Spitalstrasse 21, 4031, Basel, Switzerland.
Department of Radiology and Nuclear Medicine, Division of Interventional Radiology, University Hospital Basel, Basel, Switzerland.
Eur J Nucl Med Mol Imaging. 2024 Aug;51(10):2980-2987. doi: 10.1007/s00259-023-06410-1. Epub 2023 Aug 31.
The detection of small lung nodules in thoracoscopic procedure is difficult when the lesions are not located within the outer border of the lung. In the case of ground-glass opacities, it is often impossible to palpate the lesion. Marking lung nodules using a radiotracer is a known technique. We analysed the accuracy and safety of the technique and the potential benefits of operating in a hybrid operating room.
57 patients, including 33 (58%) females with a median age of 67 years (range 21-82) were included. In 27 patients, we marked and resected the lesion in a hybrid room. In 30 patients, the lesion was marked at the department of radiology the day before resection. [Tc]Tc-Macrosalb (Pulmocis) was used at an activity of 1 MBq in the hybrid room and at an activity of 3 MBq the day before to get technical feasible results. Radioactivity was detected using the Neoprobe detection system.
Precise detection and resection of the nodules was possible in 95% of the lesions and in 93% of the patients. Complete thoracoscopic resection was possible in 90% of the patients. Total conversion rate was 10%, but conversion due to failure of the marking of the nodule was observed in only 5% of the patients. Histology revealed 28 (37%) primary lung cancers, 24 (32%) metastases and 21 (28%) benign lesions. In 13 (23%) patients, minor complications were observed. None of them required additional interventions.
The radio-guided detection of small pulmonary nodules is very accurate and safe after CT-guided injection of [Tc]Tc-Macrosalb. Performing the operation in a hybrid room has several logistic advantages and allows using lower technetium-99m activities. The technique allows minimally invasive lung sparing resection and prevents overtreatment of benign and metastatic lesions.
当病灶不在肺的外边界内时,在胸腔镜手术中检测小的肺结节是困难的。在磨玻璃样混浊的情况下,往往无法触诊到病变。使用放射性示踪剂标记肺结节是一种已知的技术。我们分析了该技术的准确性和安全性,以及在杂交手术室中操作的潜在益处。
共纳入 57 例患者,其中 33 例(58%)为女性,中位年龄为 67 岁(范围 21-82 岁)。在 27 例患者中,我们在杂交手术室中标记并切除了病变。在 30 例患者中,病变在切除前一天在放射科进行了标记。[Tc]Tc-Macrosalb(Pulmocis)在杂交手术室中的活性为 1MBq,前一天的活性为 3MBq,以获得可行的技术结果。放射性使用 Neoprobe 检测系统进行检测。
95%的病灶和 93%的患者可以进行准确的检测和切除。90%的患者可以进行完全胸腔镜切除。总转化率为 10%,但仅在 5%的患者中观察到因结节标记失败而导致的转换。组织学显示 28 例(37%)原发性肺癌、24 例(32%)转移瘤和 21 例(28%)良性病变。13 例(23%)患者出现轻微并发症。均无需进一步干预。
经 CT 引导注射[Tc]Tc-Macrosalb 后,放射性引导检测小的肺结节非常准确和安全。在杂交手术室中进行手术具有多项后勤优势,并允许使用较低的锝-99m 活性。该技术允许进行微创性肺保留切除,防止对良性和转移性病变的过度治疗。